Why Eastman Kodak Co. (NYSE:KODK) Stock Decreased -3.41 percent in recent Trade?

The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -5.60% within the last five trades and 9.33% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 36.80% in the last 6 months […]

Why Coursera Inc (NYSE:COUR) Stock Slipped -16.77% in Last Month?

Telsey Advisory Group lowered the price target for the Coursera Inc (NYSE:COUR) stock to “an Outperform”. The rating was released on April 30, 2024, according to finviz. We previously noted in another research note published on January 19, 2024 by Goldman that downgraded the stock from a Neutral to a Sell with a price target […]

Sibanye Stillwater Limited ADR (NYSE:SBSW) Stock Price Advanced 0.63% to $4.78

Jefferies raised the price target for the Sibanye Stillwater Limited ADR (NYSE:SBSW) stock from “a Buy” to “a Sell”. The rating was released on March 13, 2024, according to finviz. The research report from RBC Capital Mkts has downgraded the stock from Outperform to Sector Perform, with a price target set at $6.50. The latest […]

Why Green Plains Inc (NASDAQ:GPRE) Stock went down -46.87% in Last Year?

BofA Securities raised the price target for the Green Plains Inc (NASDAQ:GPRE) stock to “a Buy”. The rating was released on May 12, 2023, according to finviz. The research report from Stephens has downgraded the stock from Overweight to Equal-Weight, with a price target set at $37. The stock was initiated by UBS, who disclosed […]

Everi Holdings Inc (NYSE:EVRI) Stock is trading Lower -22.18% From 200-Day SMA

B. Riley Securities raised the price target for the Everi Holdings Inc (NYSE:EVRI) stock to “a Neutral”. The rating was released on April 05, 2024, according to finviz. The research report from B. Riley Securities has initiated the stock to Buy, with a price target set at $25. The stock was resumed by Stifel, who […]

Why Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) Stock up 0.73% in Last Week?

Citigroup raised the price target for the Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) stock to “a Buy”. The rating was released on March 06, 2024, according to finviz. The research report from Jefferies has initiated the stock to Hold, with a price target set at $35. The stock was resumed by JP Morgan, who disclosed in a […]